ArticleFrontiers in pharmacology2025
Trend analysis and future projections of global burden of opioid use disorder (OUD) from 1990 to 2030.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Examining the effects of pill counts on treatment retention in buprenorphine maintenance therapy.Drug and alcohol dependence reports · 2026Article
- Clinical Efficacy and Risks of Clonidine Infusion for Sedation and Analgesia: A Narrative Review.Current pain and headache reports · 2026Review
- Who are we reaching? Identifying subgroups among individuals seeking help for opioid use disorder.Frontiers in psychiatry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Opioid Use Disorder (OUD) is a chronic medical crisis which represents significant public health challenge on global scale. We aim to provide long-term trends and future projections of OUD for effective intervention. Methods: This study utilized data from the Global Burden of Disease (GBD) study 2021 for analysis. OUD burden was assessed using absolute numbers and age-standardized rates of incidence (ASIR), prevalence (ASPR), disability-adjusted life years (ASDR), and mortality (ASMR) per 100,000 population, with 95% uncertainty intervals (UIs). Temporal trends were analyzed using joinpoint regression. Age-period-cohort (APC) models were applied to assess the independent effects of age, time period, and birth cohort on OUD burden. Decomposition analysis quantified the relative contributions of population growth, aging, and epidemiological changes to the overall burden variation. Finally, autoregressive integrated moving average (ARIMA) models were used to forecast OUD burden through 2030. Results: In 2021, an estimated 1.94 million new cases and 16.16 million prevalent cases of OUD were recorded globally, resulting in 11.22 million DALYs and nearly 99,556 deaths. The number of incidence, prevalence, DALYs and mortality of OUD all showed substantial increases. The age-standardized rates also increased but the margins were relatively small. The highest levels and fastest growth were observed in high-SDI regions, particularly North America. Males consistently exhibited higher DALY and mortality rates than females. The burden was greatest among individuals aged 15-49 years. Joinpoint analysis revealed fluctuating trends with notable increases after 2010. APC analysis showed peak incidence at ages 20-25 and declining risk in later birth cohorts. Decomposition analysis indicated that population growth and epidemiological changes were the main contributors to the rising burden. ARIMA forecasting predicted continued increases in incidence and DALYs but slight declines in prevalence and mortality by 2030. Conclusion: The global burden of opioid use disorder (OUD) has continued to rise since 1990, mainly driven by population growth and epidemiological changes. Although age-standardized rates have remained stable or increased slightly, regional disparities persist, with the highest burden in high-SDI areas. Forecasts suggest modest increases in incidence and DALYs by 2030, underscoring the need for sustained, adaptive policies and preventive strategies to mitigate the evolving opioid crisis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.